Alexandra Martin

ORCID: 0000-0003-1046-9809 · 4 papers in corpus
article 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
Gynecologic Oncology ·doi:10.1016/j.ygyno.2023.03.020

OBJECTIVE: To demonstrate that shared antibody responses in endometriosis and endometriosis-associated ovarian cancer spontaneously antagonize malignant progression and can be leveraged to develop future immunotherapies. METHODS: B cells f…

article 2023
Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286)
·doi:10.1016/j.ygyno.2023.06.192
article 2022
Utilization of immortalized B cells to identify SDCBP as a novel therapeutic target in ovarian carcinoma.
·doi:10.1200/jco.2022.40.16_suppl.e14507

e14507 Background: We hypothesized that tumor-infiltrating B cells in endometriosis and endometriosis-associated ovarian cancer can be used to identify novel, targetable antigen domains to inhibit the progression of ovarian carcinomas. We a…

2018
Systematic Review of Topical Hemostatic Agent Use in Minimally Invasive Gynecologic Surgery.
JSLS : Journal of the Society of Laparoendoscopic Surgeons ·doi:10.4293/jsls.2018.00070

Background and objectivesTo perform a systematic review of articles evaluating hemostatic effectiveness and peri-operative outcomes when topical hemostatic agents (HA) are used in minimally invasive gynecologic surgeries (MIGS) for benign c…